Asthma Inhaler Device Market Growth, Sales Projection, Emerging Trends, Regional Outlook and Future Dynamics by 2027
Asthma Inhaler Device Market Overview
The global asthma
inhaler devices market is likely to expand at 5.2 % CAGR during the
forecast period (2017-2022) owing to the increasing prevalence of asthma among
the crowd, asserts Market Research Future (MRFR). An inflammatory disease of
the lungs, asthma is characterized by the difficulty faced while breathing. The
symptoms of asthma are often triggered with exposure to allergens such as
ragweed, pollen, animal dander, and irritants such as chemical fumes and smoke.
Asthma leads to swelling of the inside walls of an asthmatic’s airways and makes
airways sensitive to irritations.
Drivers and Constraints Impacting the Market
With the increasing prevalence of asthma especially among the children, the
market is likely to propel over the assessment period. For instance, around 9
million children under five years of age die every year due to the presence of
lung diseases. The increasing disposable income and rising preference for
combination therapy for asthma treatment are boosting the global market during
the review period. Moreover, high health care spending coupled with government
strategic and collaborative endeavors in order to manage and diagnose
respiratory health problems contribute to the market growth.
On the flip side, high prices of devices, complications during inhalation,
and lack of accuracy are estimated to hamper the market growth. Moreover, side
effects such as tremor, nervousness, dizziness, irritation, nausea, muscle
pain, and others associated with using inhaler devices are presumed to inhibit
the market growth in the coming years. Moreover, competition faced from
pharmaceutical giants and new entrants entering the market is likely to affect
the market growth.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/1653
Global Asthma Inhaler Devices Market: Segmental Analysis
The global asthma inhaler devices market has been segmented on the basis of
technology, type, end-user, and region.
By mode of device type, the global inhaler devices market has been segmented
into dry-powder inhaler, metered-dose inhaler, MDI with a spacer, and others.
By mode of technology, the global inhaler devices market has been segmented
into digitally operated and manually operated inhaler devices.
By mode of end-users, the global inhaler devices market has been segmented
into research institutes, clinics, hospitals, and others.
Regional Insights
The global asthma inhaler devices market span across regions namely, Europe,
America, Asia Pacific, and the Middle East and Africa.
Among all the regions, the American market is presumed to register the
maximum market share owing to the availability of a variety of products in the
market coupled with rising patient population. According to the Centers for
Disease Control and Prevention, around 7.8 % of the U.S. population in 2015 was
diagnosed with asthma. The growth is also attributed to the presence of key
players and well-developed healthcare infrastructure in this region.
Europe is estimated to be the second largest market due to the presence of
major contributors such as France, Germany, and the U.K. The growth of the
market is mainly attributed to the presence of a high population with different
types of allergy conditions and use of respiratory devices.
Asia Pacific is considered to be the fastest growing market owing to the
increasing demand for respiratory inhalers and increasing environmental
pollution. Countries such as China and Japan are the countries holding the
maximum market share in this region. According to the Indian Chest Society, in
2015, around 300 people suffered from asthma across the globe, with India
harboring a huge patient population.
On the other hand, the Middle East and Africa are expected to register a
steady growth due to rising demand for treatment and diagnostic services for
chronic diseases.
Competitive Dashboard
The major players operating the global market are Merck & Co. Inc. (US),
GlaxoSmithKline Plc. (U.K), 3M (US), Aristopharma Ltd. (Bangladesh), SRS
PHARMACEUTICALS PVT. LTD. (India), Intas Pharmaceuticals Ltd. (India), and
others.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/asthma-inhaler-device-market-1653
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private
Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment